Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
alendronat bluefish tafla 70 mg
bluefish pharmaceuticals ab - acidum alendronicum natríum - tafla - 70 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
coxient filmuhúðuð tafla 90 mg
zentiva k.s.* - etoricoxibum inn - filmuhúðuð tafla - 90 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
maxalt smelt frostþurrkuð tafla 10 mg
n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
ostacid filmuhúðuð tafla 70 mg
williams & halls ehf.* - acidum alendronicum natríum - filmuhúðuð tafla - 70 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rivotril tafla 0,5 mg
cheplapharm arzneimittel gmbh - clonazepamum inn - tafla - 0,5 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
rivotril tafla 2 mg
cheplapharm arzneimittel gmbh - clonazepamum inn - tafla - 2 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 12,5 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 12,5 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 25 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 25 mg
Island -
Isländisch -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 50 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 50 mg
Europäische Union -
Isländisch -
EMA (European Medicines Agency)
ztalmy
marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - Önnur antiepileptics - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.